Sentences with phrase «with approval in»

's historical expenses and income is required such that the court is not obliged to «ferret out the necessary information from inadequate or incomplete financial disclosure»: Jeffery v. Motherwell, 2006 BCSC 140 at para. 23 cited with approval in Hausman v. Klukas, 2009 BCCA 32 at para. 51.

In Ontario, the reasoning in Shore has been cited with approval in obiter in Slepenkova v. Ivanov16 and applied in Wright v. Young and Rubicam Group of Companies (Wunderman) 17 and in the 2016 decision Garreton v Complete Innovations Inc. 18 In Rubicam Madam Justice Low explained her reasoning at para. 36:

«bears less resemblance to the arrangement struck down in Nyquist than it does to assistance programs upheld in our prior decisions and those discussed with approval in Nyquist.»

As well, a citation of the extent to which foreign, comparative, and international law is cited with approval in Canadian appellate courts would be informative and helpful to legal scholars and legal researchers generally.

It would be a good article for lawyers in common law Canada to read, even if the Supreme Court hadn't cited it with approval in Clements at para. 14.

As might be expected this passage has been quoted by the courts with approval in for instance Fred Perry v Brands Plaza [2012] EWCA Civ 224, [2012] All ER (D) 77 (Jun).

Several efforts to increase the mandatory retirement age for judges met with approval in the House but were not taken up by the Senate prior to adjournment.

Take the half - dozen most influential greenhouse gases, look up their concentrations in 1950 and again today, determine the consequent radiative forcings using the functions provided in Myhre (1998) and cited with approval in the IPCC's 2001 and 2007 reports, and go figure.

I can only speak about certain fields of English law but I know of many articles published in obscure places which have had a significant impact on legal analysis (I could mention one of my own which has been cited with approval in the Court of Appeal in England and the High Court of Australia and is referenced in leading works on contract law in England, Australia and the USA, but I won't because I am too modest).

With approval in hand, you'll let your lender do the rest of the work to make your loan go through.

While funding normally takes several weeks, some banks, such as Wells Fargo and PNC, have started offering online loans with approval in a few days.

Georgiana combined a perfect mastery of etiquette with a mischievous grace and ease which met with approval in the artificial and mannered atmosphere of the French...

The BC1 02 study additionally cited by the drug manufacturer was not considered because radium - 223 was not used in compliance with its approval in this study.

With this approval in federal court, the final hurdle has been cleared.

But studies show that I never actually cite any of them with approval in my writing.

Moltmann has quoted Whitehead with approval in his rejection of traditional theism.

With approvals in place giving permission to move forward, the owness is now on Facebook to show us what they plan to do with their new toy.

Tio Rico makes the application process a breeze with approvals in thirty minutes or less.

According to Penn Mutual's latest press release, the company will be offering no medical testing required policies with approvals in as quick as 24 hours, in contrast the the industry average of around a month.

And a no medical exam life insurance approval is fast, with some approvals in 15 minutes.

For their ValueGuard Whole Life Insurance, they offer protection for your entire life with face amounts up to $ 150,000 and with approvals in less than 15 minutes!

According to Penn Mutual's latest press release, the company will be offering no medical testing required policies with approvals in as quick as 24 hours, in contrast the the industry average of around a month.

And a non medical exam policy approval is fast with some approvals in 15 minutes.

Not exact matches

The approval time for products with health claims can be as along as three years in Canada, much slower than the FOSHU regulatory system in Japan or similar setups in Europe.

The Boring Company has already received approval to dig a 10.3 - mile tunnel in Baltimore beneath the Baltimore - Washington Parkway and has discussed constructing a tunnel between downtown Chicago and O'Hare International Airport with Chicago Mayor Rahm Emanuel.

DELTA TOWNSHIP, Mich. — Michigan regulators on Friday cleared DTE Energy's request to build a near - $ 1 billion natural gas power plant, the first approval of such a large facility for a regulated utility in decades and a move that coincides with the retirement of coal - fired plants.

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Then, they plan to get started with clinical trials in their journey toward FDA approval, starting with peanuts, but expanding out to the other top food allergies, such as soy, wheat, milk, and eggs.

A December survey by Public Policy Polling, a Democratic firm, found that McConnell is the least popular senator in the country, with his approval rating underwater by 30 points.

The preliminary settlement filed on Monday with the U.S. District Court in Manhattan requires a judge's approval.

In 2011, Restoration Robotics got approval from the U.S. Federal Drug Administration to begin commercial operations with its Artas System, which uses digital imaging and a robotic arm to help with the hair transplant procedure.

Work will start on a game - changing redevelopment of Forrest Chase in coming months, with fund manager ISPT expected to receive planning approval for a major revamp of the CBD mall later this week.The

Certain matters discussed in this news release are forward - looking statements that involve a number of risks and uncertainties including, but not limited to, doubts about the Company's ability to continue as a going concern, the need to obtain additional funding, risks in product development plans and schedules, rapid technological change, changes and delays in product approval and introduction, customer acceptance of new products, the impact of competitive products and pricing, market acceptance, the lengthy sales cycle, proprietary rights of the Company and its competitors, risk of operations in Israel, government regulations, dependence on third parties to manufacture products, general economic conditions and other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

Whether with marketing, distribution, regulatory approvals, or simply helping a startup «productize» its breakthrough, corporations are key players in the ecosystem.

21st Century Fox is currently trying to gain regulatory approval in the UK for a merger with Sky, both of which are owned by billionaire Rupert Murdoch.

In addition to MintyBoost ($ 19.50), the online catalog includes in - house designs like the iNecklace ($ 75), a pendant shaped like an Apple gadget's «on» button, complete with a pulsing LED light; and third - party products that have earned the «Adafruit seal of approval,» like the MaKey MaKey ($ 49.95), a device that can turn any object that conducts electricity — a coin, cat, banana — into a functioning touchpad or keyboarIn addition to MintyBoost ($ 19.50), the online catalog includes in - house designs like the iNecklace ($ 75), a pendant shaped like an Apple gadget's «on» button, complete with a pulsing LED light; and third - party products that have earned the «Adafruit seal of approval,» like the MaKey MaKey ($ 49.95), a device that can turn any object that conducts electricity — a coin, cat, banana — into a functioning touchpad or keyboarin - house designs like the iNecklace ($ 75), a pendant shaped like an Apple gadget's «on» button, complete with a pulsing LED light; and third - party products that have earned the «Adafruit seal of approval,» like the MaKey MaKey ($ 49.95), a device that can turn any object that conducts electricity — a coin, cat, banana — into a functioning touchpad or keyboard.

Factors which could cause actual results to differ materially from these forward - looking statements include such factors as the Company's ability to accomplish its business initiatives, obtain regulatory approval and protect its intellectual property; significant fluctuations in marketing expenses and ability to achieve or grow revenue, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission.

Yet there is another scenario, which, many observers believe, is just as likely: that Putin, with about $ 465 billion in foreign cash and gold in Russia's Central Bank, could try to ride out sanctions, perhaps for years, and emerge even stronger (his approval ratings are above 80 %) as the Man Who Faced Down the West.

A parallel process to cabinet approval will be the ongoing consultation with First Nations in B.C. and Alberta.

In an interview with Canadian Business deputy editor James Cowan, Odum spoke about whether the Keystone XL pipeline will ever receive U.S. approval, why cap - and - trade is good for industry, and what it will take for Canada to become a world leader in LNIn an interview with Canadian Business deputy editor James Cowan, Odum spoke about whether the Keystone XL pipeline will ever receive U.S. approval, why cap - and - trade is good for industry, and what it will take for Canada to become a world leader in LNin LNG.

With hundreds of thousands of government workers furloughed — excluding those considered essential employees — paperwork backups are likely to occur in the mortgage - approval process.

The company built its Aurora manufacturing facility specifically with the U.S. regulatory approval process in mind; the FDA, as part of its sign - off, insists on a detailed facility audit.

Exploration firm Energia Minerals says it has received shareholder approval to place $ 6 million towards its flagship Gorno zinc project in Italy, with pre-development activities planned to begin within six weeks.

TPG Telecom has lifted its stake in Amcom Telecommunications to 19.9 per cent, making it harder for Amcom to win approval at next week's shareholder meeting for its planned merger with Vocus Communications.

Further, with government approval at an all time low and an upcoming election with two of the most disliked candidates in decades, we may simply be no longer able to rely on the actions of our elected officials to regulate social goods.

Britain's housing market continued to lose momentum data showed too, with mortgage approvals at their weakest in nearly three years following the Bank of England's first interest rate hike in a decade.

Now, suppliers in Quebec are under attack with Couillard's approval and next will be jobs, Therrien lamented.

Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.